-
Freiburg Scientist is awarded the Paul Ehrlich and Ludwig Darmstaedter Prize
-
Immunologist Michael Reth is honoured for outstanding biomedical research
Located in
Newsroom
/
Press Releases 2014
-
From Moss to Mouse
-
University of Freiburg to cooperate with a biopharmaceutical company on therapy for kidney diseases
Located in
Newsroom
/
Press Releases 2015
-
Gate for Bacterial Toxins Found
-
Freiburg researchers discover a molecule that smuggles toxins from intestinal pathogens into human cells
Located in
Newsroom
/
Press Releases 2014
-
Genetic Basis of Mental Illnesses
-
Researchers hope their study will enable the development of new drugs and therapies
Located in
Newsroom
/
Press Releases 2015
-
How Alzheimer’s Peptides Shut Down Cellular Powerhouses
-
Freiburg biochemists discover new mechanisms of the brain disease
Located in
Newsroom
/
Press Releases 2014
-
How cancer cells alter bone tissue
-
Migrating tumour cells produce a protein that aids them to set up home in bones, as University of Freiburg researchers show
Located in
Newsroom
/
Press Releases 2015
-
How Toxins Activate Cellular Guides
-
A diarrhoea pathogen modifies the surface of intestinal cells, enabling bacteria to colonize it more easily
Located in
Newsroom
/
Press Releases 2016
-
Implant against High Blood Pressure
-
Aesculap AG agrees to participate in neuroloop GmbH and invest in a University of Freiburg spinoff
Located in
Newsroom
/
Press Releases 2016
-
Implantable Cuff with Electrodes
-
Freiburg researchers develop new method for lowering high blood pressure without side effects
Located in
Newsroom
/
Press Releases 2014
-
Major Award for an Immunologist from the University of Freiburg
-
Michael Reth has been awarded a 2.24 million Euro Advanced Grant from the European Research Council
Located in
Newsroom
/
Press Releases 2012
